Transatlantic workshop: drug-related progressive multifocal leukoencephalopathy

Event

Romanian is available via eTranslation, the European Commission's machine translation service.

Translate to Romanian | Important information about machine translation

Dată: Luni, 25 iulie 2011, Toată ziua
Locația: European Medicines Agency, Amsterdam, the Netherlands

A transatlantic two-day workshop co-chaired with the United States Food and Drug Administration (FDA) on drug-related progressive multifocal leukoencephalopathy (PML).

Documents

Workshop proceedings - Transatlantic workshop on drug-related progressive multifocal leukoencephalopathy (PML)

Reference Number: EMA/674403/2011

English (EN) (177.1 KB - PDF)

Prima publicare: 08/09/2011 Cea mai recent: 08/09/2011

Programme - Transatlantic workshop: Drug-related progressive multifocal leukoencephalopathy (PML)

Draft Reference Number: EMA/262331/2011

English (EN) (111.71 KB - PDF)

Prima publicare: 05/04/2011 Cea mai recent: 29/07/2011

Invitation for expressions of interest - Transatlantic workshop: drug-related progressive multifocal leukoencephalopathy (PML)

Reference Number: EMA/97508/2011

English (EN) (38.32 KB - PDF)

Prima publicare: 05/02/2011 Cea mai recent: 05/02/2011

List of participants - Transatlantic workshop: Drug-related Progressive Multifocal Leukoencephalopathy (PML)

Reference Number: EMA/582655/2011

English (EN) (143.57 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Welcome, PML - Balancing risks and benefits - the patients' view, Christoph Thalheim

English (EN) (2.06 MB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The possible mechanisms of the disease, Eugene Major

English (EN) (584.15 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The outcomes of drug-induced PML, Joseph Berger

English (EN) (730.43 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Natalizumab (Tysabri) and PML - the current figures, Brigitte Keller-Stanislawski

English (EN) (302.71 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The relationship between PML-rituximab and other immunobiologicals: an overview, Renaud Du Pasquier

English (EN) (471.83 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The risk in transplanted patients, Marco Tuccori

English (EN) (286.38 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Activities in USA, the experience of FDA Neurology Division, Russel Katz

English (EN) (85.71 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - PML: Risk communication in the EU, Rafe Suvarna

English (EN) (401.22 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Changes in the incidence of PML in Tysabri-treated patiens, Alice Hughes

English (EN) (128.35 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - A common case definition for PML, Dirk Mentzer

English (EN) (192.64 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The Italian natalizumab registry, G. Tedeschi

English (EN) (434.47 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The TYSEDMUS Study, Christian Confavreux

English (EN) (751.35 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Industry Experience with PML, Carmen Bozic

English (EN) (193.7 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Development of models for testing possible treatments, Igor Koralnik

English (EN) (1.87 MB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Discovery and development of PML treatments, Teresa Compton

English (EN) (516.37 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Evidence about plasma exchange in natalizumab related PML, Ralf Gold

English (EN) (2.46 MB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Immune Reconstitution Inflammatory Syndrome, Joseph Berger

English (EN) (1.22 MB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - PML development, Heinz Wiendl

English (EN) (1019.16 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Diagnosing PML, Joseph Berger

English (EN) (1.63 MB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Viral subtypes and the development of the disease: what is the evidence, Igor Koralnik

English (EN) (3.75 MB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The research in the field: Where to progress?, Eugene Major

English (EN) (295.37 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Regulators initiative, research agenda, Ana Hidalgo

English (EN) (299.34 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Research Agendas, Eugene Major

English (EN) (270.76 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The Interface of Academia and Clinical Practice, Joseph Berger

English (EN) (288.89 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - PML consortium - industry, Susan Goelz

English (EN) (229.23 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Challenges and opportunities from public private partnerships, Richard Bergstrà¶m

English (EN) (442.6 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The importance of clarity in relationships and transparency, Henry FItt

English (EN) (256.69 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Drug Safety Surveillance Initiatives, Gerald Dal Pan

English (EN) (188.64 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - How to facilitate the communicationsdata exchange, Janice Soreth

English (EN) (1.1 MB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Public funding of research - EU perspective, Stefanie Prilla

English (EN) (141.04 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Public funding of research - US, Eugene Major

English (EN) (591.5 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - The role of the pharmaceutical industry, Sophie Banzet

English (EN) (45.68 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Public Private Partnerships as funders, Hugh Laverty

English (EN) (739.34 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - EU Regulators perspective, Peter Arlett

English (EN) (14.4 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - US Regulators perspective, Russell Katz

English (EN) (23.58 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Industry PML consortium view, Sophie Banzet

English (EN) (23.08 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - PML London Clinical Researchers perspective, Igor Koralnik

English (EN) (86.12 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Benefits of Public Health, Eugene Major

English (EN) (33.23 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - Discussion 'progress for the benefit of public health', Ralf Gold

English (EN) (51.94 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - What patients and caregivers want to happen now - priorities for action, Christoph Thalheim

English (EN) (451.47 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Presentation - PML Final Conclusions, Peter Arlett

English (EN) (25.79 KB - PDF)

Prima publicare: 29/07/2011 Cea mai recent: 29/07/2011

Multimedia